Publications by authors named "Alan Gill"

Claim this Profile
P
PERK modulation, with GSK2606414, Sephin1 or salubrinal, failed to produce therapeutic benefits in the SOD1G93A mouse model of ALS.
Fernando G Vieira, Valerie R Tassinari, Joshua D Kidd, Andrew Moreno, Kenneth Thompson, Alan Gill

PLoS One· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The anti-CD40L monoclonal antibody AT-1501 promotes islet and kidney allograft survival and function in nonhuman primates.
Imran J Anwar, Dora M Berman, Isabel DeLaura, Qimeng Gao, Melissa A Willman, Alan Gill, Cindy Gill

Sci Transl Med· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SOD1-positive aggregate accumulation in the CNS predicts slower disease progression and increased longevity in a mutant SOD1 mouse model of ALS.
Cindy Gill, James P Phelan, Theo Hatzipetros, Joshua D Kidd, Valerie R Tassinari, Alan Gill

Sci Rep· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase IIa trial of fingolimod for amyotrophic lateral sclerosis demonstrates acceptable acute safety and tolerability.
James D Berry, Sabrina Paganoni, Nazem Atassi, Eric A Macklin, Namita Goyal, Alan Gill

Muscle Nerve· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CuATSM efficacy is independently replicated in a SOD1 mouse model of ALS while unmetallated ATSM therapy fails to reveal benefits.
Fernando G Vieira, Theo Hatzipetros, Kenneth Thompson, Andy J Moreno, Joshua D Kidd, Alan Gill

IBRO Rep· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Guanabenz Treatment Accelerates Disease in a Mutant SOD1 Mouse Model of ALS.
Fernando G Vieira, Qinggong Ping, Andy J Moreno, Joshua D Kidd, Kenneth Thompson, Alan Gill

PLoS One· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dexpramipexole is ineffective in two models of ALS related neurodegeneration.
Fernando G Vieira, Eva LaDow, Andy Moreno, Joshua D Kidd, Beth Levine, Alan Gill

PLoS One· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Quick Phenotypic Neurological Scoring System for Evaluating Disease Progression in the SOD1-G93A Mouse Model of ALS.
Theo Hatzipetros, Joshua D Kidd, Andy J Moreno, Kenneth Thompson, Alan Gill

J Vis Exp· October 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Inquiries: Does exercise alleviate symptoms of depression?
Alan Gill, Rosalind Womack, Sarah Safranek

J Fam Pract· September 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
From transcriptome analysis to therapeutic anti-CD40L treatment in the SOD1 model of amyotrophic lateral sclerosis.
John M Lincecum, Fernando G Vieira, Monica Z Wang, Kenneth Thompson, Gerald S De Zutter, Alan Gill

Nat Genet· May 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Protective effect of tonapofylline (BG9928), an adenosine A1 receptor antagonist, against cisplatin-induced acute kidney injury in rats.
Alan Gill, Kathleen Wortham, Don Costa, Wendell Davis, Barry Ticho

Am J Nephrol· March 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
No benefit from chronic lithium dosing in a sibling-matched, gender balanced, investigator-blinded trial using a standard mouse model of familial ALS.
Alan Gill, Joshua Kidd, Fernando Vieira, Kenneth Thompson, Steven Perrin

PLoS One· August 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SM16, an orally active TGF-beta type I receptor inhibitor prevents myofibroblast induction and vascular fibrosis in the rat carotid injury model.
Kai Fu, Michael J Corbley, Lihong Sun, Jessica E Friedman, Feng Shan, Alan Gill

Arterioscler Thromb Vasc Biol· April 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
N-terminally PEGylated human interferon-beta-1a with improved pharmacokinetic properties and in vivo efficacy in a melanoma angiogenesis model.
Darren P Baker, Edward Y Lin, Kochung Lin, Maria Pellegrini, Russell C Petter, Alan Gill

Bioconjug Chem· September 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expression, purification, and characterization of rat interferon-beta, and preparation of an N-terminally PEGylated form with improved pharmacokinetic parameters.
Robert M Arduini, Zhifang Li, Alan Rapoza, Robert Gronke, Donna M Hess, Alan Gill

Protein Expr Purif· April 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expression of Sonic hedgehog-Fc fusion protein in Pichia pastoris. Identification and control of post-translational, chemical, and proteolytic modifications.
Renée I Shapiro, Dingyi Wen, Melissa Levesque, Xiaoping Hronowski, Alan Gill

Protein Expr Purif· June 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of potent and novel alpha4beta1 antagonists using in silico screening.
Juswinder Singh, Herman Van Vlijmen, Yusheng Liao, Wen-Cherng Lee, Mark Cornebise, Alan Gill

J Med Chem· July 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Extraction and separation of urinary catecholamines as their diphenyl boronate complexes using C18 solid-phase extraction sorbent and high-performance liquid chromatography.
Dinesh Talwar, Cathie Williamson, Allison McLaughlin, Alan Gill, Denis St J O'Reilly

J Chromatogr B Analyt Technol Biomed Life Sci· April 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-acting forms of Sonic hedgehog with improved pharmacokinetic and pharmacodynamic properties are efficacious in a nerve injury model.
R Blake Pepinsky, Renee I Shapiro, Shaoshan Wang, Abhijit Chakraborty, Alan Gill

J Pharm Sci· February 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis